Sökning: onr:"swepub:oai:lup.lub.lu.se:e05b32d0-f8ba-481d-aabc-3f2c9b96967a" >
Prophylaxis in seve...
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)
-
Abshire, T. C. (författare)
-
Federici, A. B. (författare)
-
Alvarez, M. T. (författare)
-
visa fler...
-
Bowen, J. (författare)
-
Carcao, M. D. (författare)
-
Gill, J. Cox (författare)
-
Key, N. S. (författare)
-
Kouides, P. A. (författare)
-
Kurnik, K. (författare)
-
Lail, A. E. (författare)
-
Leebeek, F. W. G. (författare)
-
Makris, M. (författare)
-
Mannucci, P. M. (författare)
-
Winikoff, R. (författare)
-
- Berntorp, Erik (författare)
- Lund University,Lunds universitet,Klinisk koagulationsmedicin, Malmö,Forskargrupper vid Lunds universitet,Clinical Coagulation, Malmö,Lund University Research Groups
-
visa färre...
-
(creator_code:org_t)
- 2012-07-23
- 2013
- Engelska.
-
Ingår i: Haemophilia. - : Wiley. - 1351-8216. ; 19:1, s. 76-81
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://europepmc.or...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- The bleeding patterns of severe von Willebrand's disease (VWD) adversely affect quality of life, and may be life threatening. There is a presumed role for prophylaxis with VWF-containing concentrates, but data are scarce. The von Willebrand Disease Prophylaxis Network (VWD PN) was formed to investigate the role of prophylaxis in clinically severe VWD that is not responsive to other treatment(s). Using a retrospective design, the effect of prophylaxis was studied. Availability of records to document, or reliably assess, the type and frequency of bleeding episodes prior to, and after, the initiation of prophylaxis was required. Annualized bleeding rates were calculated for the period prior to prophylaxis, during prophylaxis and by primary bleeding indication defined as the site accounting for more than half of all bleeding symptoms. The Wilcoxon signed-rank test of differences in the medians was used. Sixty-one subjects from 20 centres in 10 countries were enrolled. Data for 59 were used in the analysis. The median age at onset of prophylaxis was 22.4 years. Type 3 VWD accounted for the largest number (N = 34, 57.6%). Differences in bleeding rates within individuals during compared with before prophylaxis were significant for the total group (P < 0.0001), and for those with primary bleeding indications of epistaxis (P = 0.0005), joint bleeding (P = 0.002) and GI bleeding (P = 0.001). The effect of prophylaxis was similar among those age < 18 years and those >= 18. One person developed an inhibitor during treatment. We conclude that prophylactic treatment of VWD is efficacious.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
Nyckelord
- bleeding rate
- epistaxis
- gastrointestinal bleeding
- joint bleeding
- prophylaxis
- severe VWD
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Abshire, T. C.
-
Federici, A. B.
-
Alvarez, M. T.
-
Bowen, J.
-
Carcao, M. D.
-
Gill, J. Cox
-
visa fler...
-
Key, N. S.
-
Kouides, P. A.
-
Kurnik, K.
-
Lail, A. E.
-
Leebeek, F. W. G ...
-
Makris, M.
-
Mannucci, P. M.
-
Winikoff, R.
-
Berntorp, Erik
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
- Artiklar i publikationen
-
Haemophilia
- Av lärosätet
-
Lunds universitet